Optimization of the indolyl quinolinone class of KDR (VEGFR-2) kinase inhibitors: effects of 5-amido- and 5-sulphonamido-indolyl groups on pharmacokinetics and hERG binding

Modifications to the basic side-chain of early lead structures of the indolyl quinolinone class of KDR kinase inhibitors resulted in improved pharmacokinetic and ancillary profiles. Specifically, compounds bearing 5-amido- and 5-sulphonamido-indolyl substituents exhibited lower plasma clearance and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2004-01, Vol.14 (2), p.351-355
Hauptverfasser: Fraley, Mark E., Arrington, Kenneth L., Buser, Carolyn A., Ciecko, Patrice A., Coll, Kathleen E., Fernandes, Christine, Hartman, George D., Hoffman, William F., Lynch, Joseph J., McFall, Rosemary C., Rickert, Keith, Singh, Romi, Smith, Sheri, Thomas, Kenneth A., Wong, Bradley K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Modifications to the basic side-chain of early lead structures of the indolyl quinolinone class of KDR kinase inhibitors resulted in improved pharmacokinetic and ancillary profiles. Specifically, compounds bearing 5-amido- and 5-sulphonamido-indolyl substituents exhibited lower plasma clearance and weaker binding affinity for the I Kr potassium channel hERG. ©2003 Elsevier Science Ltd. All rights reserved. Graphic
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2003.11.007